%0
Generic
%T
Intermittent high-dose intravenous interferon alpha 2b (IFNa2b) for adjuvant treatment of stage III malignant melanoma: Final analysis of a randomized phase III DeCOG-trial (NCT00226408).
%A Mohr, Peter
%A Hauschild, Axel
%A Trefzer, Uwe
%A Enk, Alexander
%A Tilgen, Wolfgang
%A Loquai, Carmen
%A Gogas, Helen
%A Haalck, Thomas
%A Koller, Josef
%A Schadendorf, Dirk
%A Dummer, Reinhard
%A Gutzmer, Ralf
%A Brockmeyer, Norbert
%A Hölzle, Erhard
%A Sunderkötter, Cord
%A Mauch, Cornelia
%A Stein, Anette
%A Schneider, Lars
%A Podda, Maurizio
%A Weichenthal, Michael
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2012
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2